If you need more lookups,
subscriptions start at $34 USD/month.
Bjarke Ebert Location
Copenhagen, DK
Bjarke Ebert Work
Chief medical advisor @ (April 2019 - Present)
Lead Medical Advisor; Brintellix Science Team @ (January 2015 - Present)
Senior Medical Advisor @ (January 2010 - Present)
Adjunct Professor in Pharmacology at the Danish Pharmaceutical University @ (January 2002 - January 2012)
Doctor of Science; University of Copenhagen. @ (January 2008 - January 2008)
Principal Scientist @ (January 2001 - January 2003)
Full time academic at Biological Research, @ (January 2000 - January 2001)
Associate Professor @ (January 1996 - January 2000)
Assistant professor @ (January 1995 - January 1999)
Research Fellow; Sponsored by the Lundbeck Foundation @ (January 1993 - January 1995)
Ph.D in Molecular Pharmacology @ (January 1992 - January 1992)
PhD student @ (January 1989 - January 1992)
Bjarke Ebert Education
Danmarks Farmaceutiske Universitet
Masters (Pharmacy)
1982-1988
Bjarke Ebert Skills
Pharmacology
Drug Discovery
Clinical Development
Pharmaceutical Industry
Molecular Pharmacology
Neuroscience
Neuropharmacology
Clinical Trials
CRO
Drug Development
Pharmaceutics
Medical Affairs
Clinical Research
Pharmacokinetics
Molecular Biology
Oncology
Biotechnology
Science
Medicine
Pharmacovigilance
Medical Writing
Clinical Pharmacology
Life Sciences
GCP
Pharmaceutical Research
Research
Translational Medicine
In Vivo
Medicinal Chemistry
Bjarke Ebert Summary
Bjarke Ebert, based in Copenhagen, DK, is currently a Chief medical advisor at Lundbeck. Bjarke Ebert brings experience from previous roles at Lundbeck and Faculty of Pharmaceutical Sciences, University of Copenhagen. Bjarke Ebert holds a 1982 - 1988 Masters in Pharmacy @ Danmarks Farmaceutiske Universitet. With a robust skill set that includes Pharmacology, Drug Discovery, Clinical Development, Pharmaceutical Industry, Molecular Pharmacology and more. Bjarke Ebert has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Bjarke Ebert?
Find contact details for 700 million professionals.